Say something
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent.
Sun Pharma stock surged 2 percent to Rs 707, while Ranbaxy Laboratories gained 2 percent to Rs 534.
USFDA has granted approval to Ranbaxy’s subsidiary Ohm Laboratories to manufacture and sell generic Diovan in the US.
Source: IIFL
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
Seeking a resilient, agile architecture The Ministry of Health and Family Welfare supports health policy in India by ...
Amazon.com Inc. closed a $3.9 billion deal to acquire a primary-care clinic operator, joining a number of businesses dep...
The impact of the ongoing global economic downturn has hit the start-up ecosystem back home across sectors resulting in ...
Transasia Bio-Medicals Ltd unveiled two new “Made in India” products in its growing portfolio of in vitro diagnostic...
In a bid to transform healthcare education and services in India, the All-India Institute of Medical Sciences (AIIMS), J...
Flipkart Health+, the digital healthcare marketplace platform of India’s homegrown Flipkart Group, announced the launc...
Manipal Hospitals announced a strategic partnership with ConnectedLife built with Google Cloud to use Fitbit’s wearabl...
Flipkart Health+ today announced the appointment of Prashant Jhaveri as its Chief Executive Officer (CEO) to lead Flipka...
BSE has signed an MoU with Onsurity Technologies, India’s 1st monthly subscription led new-age employee healthcare pla...
Healthspring, a pioneer of primary healthcare in India partners with NIRAMAI Health Analytix, India’s leading deep-tec...
